Tracking 43+ Companies & 126+ Open Roles
The career platform for psychedelic medicine
Company intelligence, jobs, clinical trials, and practitioner resources — everything you need to build a career in the emerging psychedelic industry.
43+
Companies tracked
126+
Open positions
2371
Active clinical trials
17
States with legislation
NYU Langone HealthPsilocybin · Opioid Use DisorderPhase 2·
Sharmin GhaznaviPsilocybin · Major Depressive DisorderPhase 3·
Madeline FieldsKetamine · Drug Resistant EpilepsyPhase 2·
New York State Psychiatric InstituteCI-581a · Post-acute Sequelae of COVID-19Phase 2·
Robin Carhart-Harris, PhD, MAPsilocybin · Healthy Participants With Lower-than-average Mental Well-beingPhase 2·
M.D. Anderson Cancer CenterPsilocybin · Depression, AnxietyPhase 2·
Icahn School of Medicine at Mount SinaiKetamine · Major Depressive DisorderPhase 2·
University Hospital, Basel, SwitzerlandLysergic · Cluster HeadachePhase 2·
COMPASS PathwaysCOMP360 · Treatment Resistant DepressionPhase 3·
Charles RaisonPsilocybin · DepressionPhase 2·
NYU Langone HealthPsilocybin · Opioid Use DisorderPhase 2·
Sharmin GhaznaviPsilocybin · Major Depressive DisorderPhase 3·
Madeline FieldsKetamine · Drug Resistant EpilepsyPhase 2·
New York State Psychiatric InstituteCI-581a · Post-acute Sequelae of COVID-19Phase 2·
Robin Carhart-Harris, PhD, MAPsilocybin · Healthy Participants With Lower-than-average Mental Well-beingPhase 2·
M.D. Anderson Cancer CenterPsilocybin · Depression, AnxietyPhase 2·
Icahn School of Medicine at Mount SinaiKetamine · Major Depressive DisorderPhase 2·
University Hospital, Basel, SwitzerlandLysergic · Cluster HeadachePhase 2·
COMPASS PathwaysCOMP360 · Treatment Resistant DepressionPhase 3·
Charles RaisonPsilocybin · DepressionPhase 2·
Companies
The psychedelic medicine ecosystem
Stay ahead of the industry
Get updates on new job listings, clinical trial progress, and regulatory changes across all 50 states.